Beta Drugs Ltd vs Deep Health Ai India Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 18, 2026

Key Highlights

The Latest Trading Price of Beta Drugs Ltd is ₹ 1195 as of 18 May 11:54 . The P/E Ratio of Beta Drugs Ltd changed from 32.5 on March 2024 to 19.6 on March 2023 . This represents a CAGR of -9.62% over 5 yearsThe P/E Ratio of Deep Health AI India Ltd changed from 65.7 on March 2024 to 0 on March 2023 . This represents a CAGR of -100.00% over 5 years The Market Cap of Beta Drugs Ltd changed from ₹ 1186 crore on March 2024 to ₹ 602.74 crore on March 2023 . This represents a CAGR of -12.66% over 5 yearsThe Market Cap of Deep Health AI India Ltd changed from ₹ 18.91 crore on March 2024 to ₹ 0 crore on March 2023 . This represents a CAGR of -100.00% over 5 years The revenue of Beta Drugs Ltd for the Mar '26 is ₹ 96.86 crore as compare to the Dec '25 revenue of ₹ 89.58 crore. This represent the growth of 8.13% The revenue of Deep Health AI India Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 revenue of ₹ 4.21 crore. This represent the decline of -100% The ebitda of Beta Drugs Ltd for the Mar '26 is ₹ 20.57 crore as compare to the Dec '25 ebitda of ₹ 19.3 crore. This represent the growth of 6.58% The ebitda of Deep Health AI India Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 ebitda of ₹ 3.67 crore. This represent the decline of -100% The net profit of Beta Drugs Ltd changed from ₹ 8.95 crore to ₹ 9.05 crore over 6 quarters. This represents a CAGR of 0.74% The net profit of Deep Health AI India Ltd changed from ₹ 0.29 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of -100.00% The Dividend Payout of Beta Drugs Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Deep Health AI India Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Beta Drugs Ltd

Beta Drugs Limited was incorporated as a private limited company with the name 'Beta Drugs Private limited' at Himachal Pradesh on September 21, 2005.
Subsequently, the company was converted in to public limited company and the name of the company was changed to 'Beta Drugs Limited' on August 11, 2017 Beta Drugs is a part of Adley Group.
Adley Group was founded in the year 1985, by its promoter Vijay Batra, who has more than twenty five years of experience in manufacture of pharmaceutical products in India.
The Company is a pharmaceutical formulation manufacturing company engaged in developing, manufacturing and marketing of drug products for domestic and international customers.
The Promoter Vijay Batra, took over the company from Kiran Goyal, Deepak Kumar Prince Bharti and Rohit Bansal in the year 2014.

About Deep Health AI India Ltd

Deep Diamond India Limited was established in 1994, with the object to engaged in the manufacture and wholesale of gold set jewellery with diamonds.
The company also deals in loose diamonds, solitaires, and gold frames.
It offers Pendants, Nose pins, Rings, Bangles, Earrings, Pendant sets, Necklace sets, Bracelets, and others. From financial year 2022-23, the Company has also started business of providing consultancy service to Pharmaceutical Industry. During year 2023, Company diversified its business into pharmaceuticals business with professional management team at its Board.
Located in Mumbai, Deep Diamond India is a pharmaceutical company that focuses on developing and marketing innovative drugs and therapies to address unmet medical needs.
Their product portfolio includes prescription drugs, over-the-counter medicines, and medical devices.

FAQs for the comparison of Beta Drugs Ltd and Deep Health AI India Ltd

Which company has a larger market capitalization, Beta Drugs Ltd or Deep Diamond India Ltd?

Market cap of Beta Drugs Ltd is 1,289 Cr while Market cap of Deep Diamond India Ltd is 33 Cr

What are the key factors driving the stock performance of Beta Drugs Ltd and Deep Diamond India Ltd?

The stock performance of Beta Drugs Ltd and Deep Diamond India Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Beta Drugs Ltd and Deep Diamond India Ltd?

As of May 18, 2026, the Beta Drugs Ltd stock price is INR ₹1271.9. On the other hand, Deep Diamond India Ltd stock price is INR ₹2.33.

How do dividend payouts of Beta Drugs Ltd and Deep Diamond India Ltd compare?

To compare the dividend payouts of Beta Drugs Ltd and Deep Diamond India Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.